Clinical Supply Management Resources
-
Direct-To-Patient Supply: Industry Perception And Future Trends
5/5/2022
To better understand sponsors’ perspectives on DTP distribution of clinical supplies, 234 individuals involved in clinical supply and operations were recently surveyed. Click to get the results!
-
Winning The Race To FPI With Early Randomization And Trial Supply Management
9/8/2022
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
RTSM/IRT In Clinical Trials: The Complete Guide
1/27/2025
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution
10/4/2024
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
5 Ways RTSM Supports Study Managers
3/15/2023
As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate, real-time study data.
-
Finding The Optimal IRT/RTSM Design For Your Clinical Trial
10/4/2024
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Direct To Patient (DTP) Clinical Trials
1/6/2022
DtP trials are a win-win for patients and sponsors. The purpose of this white paper is to provide in-depth information on the various DtP approaches while offering insight into best practices when incorporating DtP into the protocol.
-
Running Decentralized Trials At Scale
5/8/2026
Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
Decentralized Clinical Trials: A Win For Patients, Sponsors, & Investigators
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.